Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Porter

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Texas Heart Institute Journal|January 1, 1991
The use of percutaneous transluminal coronary angioplasty in myocardial infarctionD J McSweyn, J L Vacek, O W Robuck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Who is most likely to enjoy long term survival after cardiac transplantation? Risk stratification in a 10 year multi-institutional experienceJ Kirklin, L W. Miller, R N. Brown, et al.
Circulation|December 1, 1996
Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database GroupR J Rodeheffer, D C Naftel, L W Stevenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 1999
An analysis of the effect of age on survival after heart transplantA M Borkon, G F Muehlebach, P G Jones, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Texas Heart Institute Journal|January 1, 1991
The use of percutaneous transluminal coronary angioplasty in myocardial infarctionD J McSweyn, J L Vacek, O W Robuck, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 16, 2001
Who is most likely to enjoy long term survival after cardiac transplantation? Risk stratification in a 10 year multi-institutional experienceJ Kirklin, L W. Miller, R N. Brown, et al.
Circulation|December 1, 1996
Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database GroupR J Rodeheffer, D C Naftel, L W Stevenson, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 19, 1999
An analysis of the effect of age on survival after heart transplantA M Borkon, G F Muehlebach, P G Jones, et al.
Pageof 5